Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis

References

Page 1

	Year	Citations
Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) Scott M. Grundy JAMA Metabolic SyndromeHypertensionSecond ReportPrimary PreventionCardiovascular Disease	1993	27.9K
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Evaluation Expert Panel on Detection JAMA OtorhinolaryngologyHyperlipidemiaSurgeryMedical DiagnosisWebsite Uses Cookies	2001	25.8K
Risk of Myocardial Infarction in Patients With Psoriasis Joel M. Gelfand, Andrea L. Neimann, Daniel B. Shin, JAMA	2006	1.9K
American College of Endocrinology Position Statement on the Insulin Resistance Syndrome Daniel Einhorn Endocrine Practice Insulin ResistanceMetabolic SyndromeEndocrinology Position StatementDiabetes ManagementHealth Policy	2003	1.1K
Prevalence of cardiovascular risk factors in patients with psoriasis Andrea L. Neimann, Daniel B. Shin, Xingmei Wang, Journal of the American Academy of Dermatology MedicineClinical DermatologyCardiovascular Risk FactorsDermatologyPublic Health	2006	1K
Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart Guillermo Torre‐Amione, Samir Kapadia, Joseph Lee, Circulation	1996	994
Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α Toru Kubota, Charles F. McTiernan, Carole S. Frye, Circulation Research	1997	822
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis Dorothea M. Sommer, Stefan Jenisch, M Suchán, Archives of Dermatological Research Metabolic SyndromeAutoimmune DiseaseMetabolic DisorderMedicineClinical Epidemiology	2006	667
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. Cecilia M. Giachelli, Na-Young Bae, M Almeida, Journal of Clinical Investigation Vascular DiseaseSclerostinPathologyOsteoporosisInflammation	1993	642
High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. Catherine M. Shanahan, N. Cary, James C. Metcalfe, Journal of Clinical Investigation Vascular DiseaseEngineeringSclerostinMolecular RegulationPathology	1994	610

Page 1